For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240129:nRSc8115Aa&default-theme=true
RNS Number : 8115A Spire Healthcare Group PLC 29 January 2024
Spire Healthcare Group plc
('Spire Healthcare', 'the Company' or 'the Group')
Notice of Preliminary Results
29 January 2024
Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group
in the UK, will announce its preliminary results for the year ended 31
December 2023 on Thursday, 29 February 2024.
A presentation for sell-side analysts and institutional investors will be held
on the day of the preliminary results announcement at 9.00am GMT at the
offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ.
Refreshments will be available from 8.30am. If you wish to attend the
presentation, please contact Instinctif Partners at spire@instinctif.com
(mailto:spire@instinctif.com) .
Following the presentation, there will be a moderated Q&A session.
For those who cannot attend in person, the presentation will also be
accessible via live Zoom webcast.
Click the following link to register in advance for the Zoom webcast and to
receive access details:
https://spirehealthcare.zoom.us/webinar/register/WN_M9WnWjkDRzWqDVic-IA8VQ
(https://spirehealthcare.zoom.us/webinar/register/WN_M9WnWjkDRzWqDVic-IA8VQ)
A recording of the webcast will be made available from 1.00 pm on 29 February
on the Spire Healthcare website, https://www.investors.spirehealthcare.com
(https://www.investors.spirehealthcare.com)
- Ends -
For further information please contact:
Spire Healthcare
Angus Prentice - Director of Investor Relations +44 (0)7974 982 512
Instinctif Partners
Damian Reece +44 (0)7931 598 593
Guy Scarborough +44 (0)7917 178 920
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (https://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, with 39 hospitals and over 30 clinics,
medical centres and consulting rooms across England, Wales and Scotland. It
operates a network of private GPs and provides occupational health services to
over 700 corporate clients.
Working in partnership with over 8,760 experienced consultants, Spire
Healthcare delivered tailored, personalised care to approximately 926,500
inpatients, outpatients and day-case patients in 2022, and is the leading
private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. The Group's well-located and scalable
hospitals have delivered successful and award-winning clinical outcomes,
positioning the Group well with patients, consultants, the NHS, GPs and
Private Medical Insurance (PMI) providers. 98% of Spire Healthcare's inspected
hospitals and clinics are rated 'Good', 'Outstanding' or the equivalent by
health inspectors in England, Scotland and Wales.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOREASFLAFFLEFA